Rhino 7 Platinum 30000 Capsules recall
Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
Why was Rhino 7 Platinum 30000 Capsules recalled?
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots remaining within expiry.
- Product
- Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
- Recalling firm
- Motto International Corp
- Quantity
- 5 boxes
- Distribution
- TX
- Recall date
- January 22, 2020
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)